Curaleaf Holdings (CURLF) Share-based Compensation Growth (1y) (2020 - 2024)
Curaleaf Holdings (CURLF) Share-based Compensation Growth (1y) (2020 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | 5.26% |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | -36.59% |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | -0.11% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | -49.74% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -18.06% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 23.11% |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | -65.00% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Curaleaf Holdings | 2.50 Bn | 2.40 Bn | 169.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -449.26% |
| Sep 30, 2024 | -3.29% |
| Dec 31, 2023 | 136.17% |
| Sep 30, 2023 | -37.74% |
| Dec 31, 2022 | -633.27% |
| Sep 30, 2022 | -24.18% |
| Jun 30, 2022 | -67.13% |
| Mar 31, 2022 | 3.79% |
| Dec 31, 2021 | -76.88% |
| Sep 30, 2021 | 142.73% |
| Jun 30, 2021 | 189.25% |
| Mar 31, 2021 | 9.02% |
| Dec 31, 2020 | 130.96% |